The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease

NCT00002001 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Zidovudine
DRUG: Zalcitabine
DRUG: Didanosine

Sponsor

Glaxo Wellcome